Cargando…

Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients

AIMS: To present the clinical, indocyanine green angiography (ICGA) features and results of treatment for polypoidal choroidal vasculopathy (PCV) in Indian patients by a retrospective chart review. MATERIALS AND METHODS: Forty five patients with PCV underwent complete ocular examination, fluorescein...

Descripción completa

Detalles Bibliográficos
Autores principales: Anantharaman, Giridhar, Ramkumar, Gudapati, Gopalakrishnan, Mahesh, Rajput, Alpesh
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992915/
https://www.ncbi.nlm.nih.gov/pubmed/20689195
http://dx.doi.org/10.4103/0301-4738.67052
_version_ 1782192789325348864
author Anantharaman, Giridhar
Ramkumar, Gudapati
Gopalakrishnan, Mahesh
Rajput, Alpesh
author_facet Anantharaman, Giridhar
Ramkumar, Gudapati
Gopalakrishnan, Mahesh
Rajput, Alpesh
author_sort Anantharaman, Giridhar
collection PubMed
description AIMS: To present the clinical, indocyanine green angiography (ICGA) features and results of treatment for polypoidal choroidal vasculopathy (PCV) in Indian patients by a retrospective chart review. MATERIALS AND METHODS: Forty five patients with PCV underwent complete ocular examination, fluorescein angiography (FFA) and ICGA. Treatment was advised for patients with macular involvement and progressive loss of visual acuity. Demographic data, clinical features and results of treatment were analyzed. RESULTS: Mean age at presentation was 61.06 years. Mean follow up was 18 months. The disease was more prevalent in males. Forty three patients had unilateral disease. The most common location of polyps in ICGA was subfoveal (42.5%). Exudative form was seen in 34 of the 47 eyes and the remaining 13 eyes had a hemorrhagic presentation. Thirty four eyes underwent treatment which included thermal laser (n = 11), photodynamic therapy (PDT) (n = 11) and transpupillary thermo therapy (TTT) (n = 12). Statistical analysis was done using the Chi-square test. Subgroup analysis of visual outcome following various modalities of treatment showed that the results of PDT (P < 0.001) and thermal laser (P < 0.001) were statistically significant. CONCLUSIONS: PCV is an important differential diagnosis in patients presenting with serosanginous maculopathy and submacular hemorrhage. The disease was more prevalent in males and was unilateral in the Indian population. Timely intervention in cases with symptomatic polyps could achieve stabilization of visual acuity. Thermal laser and PDT were safe and effective.
format Text
id pubmed-2992915
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29929152010-12-14 Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients Anantharaman, Giridhar Ramkumar, Gudapati Gopalakrishnan, Mahesh Rajput, Alpesh Indian J Ophthalmol Original Article AIMS: To present the clinical, indocyanine green angiography (ICGA) features and results of treatment for polypoidal choroidal vasculopathy (PCV) in Indian patients by a retrospective chart review. MATERIALS AND METHODS: Forty five patients with PCV underwent complete ocular examination, fluorescein angiography (FFA) and ICGA. Treatment was advised for patients with macular involvement and progressive loss of visual acuity. Demographic data, clinical features and results of treatment were analyzed. RESULTS: Mean age at presentation was 61.06 years. Mean follow up was 18 months. The disease was more prevalent in males. Forty three patients had unilateral disease. The most common location of polyps in ICGA was subfoveal (42.5%). Exudative form was seen in 34 of the 47 eyes and the remaining 13 eyes had a hemorrhagic presentation. Thirty four eyes underwent treatment which included thermal laser (n = 11), photodynamic therapy (PDT) (n = 11) and transpupillary thermo therapy (TTT) (n = 12). Statistical analysis was done using the Chi-square test. Subgroup analysis of visual outcome following various modalities of treatment showed that the results of PDT (P < 0.001) and thermal laser (P < 0.001) were statistically significant. CONCLUSIONS: PCV is an important differential diagnosis in patients presenting with serosanginous maculopathy and submacular hemorrhage. The disease was more prevalent in males and was unilateral in the Indian population. Timely intervention in cases with symptomatic polyps could achieve stabilization of visual acuity. Thermal laser and PDT were safe and effective. Medknow Publications 2010 /pmc/articles/PMC2992915/ /pubmed/20689195 http://dx.doi.org/10.4103/0301-4738.67052 Text en © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Anantharaman, Giridhar
Ramkumar, Gudapati
Gopalakrishnan, Mahesh
Rajput, Alpesh
Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients
title Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients
title_full Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients
title_fullStr Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients
title_full_unstemmed Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients
title_short Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients
title_sort clinical features, management and visual outcome of polypoidal choroidal vasculopathy in indian patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992915/
https://www.ncbi.nlm.nih.gov/pubmed/20689195
http://dx.doi.org/10.4103/0301-4738.67052
work_keys_str_mv AT anantharamangiridhar clinicalfeaturesmanagementandvisualoutcomeofpolypoidalchoroidalvasculopathyinindianpatients
AT ramkumargudapati clinicalfeaturesmanagementandvisualoutcomeofpolypoidalchoroidalvasculopathyinindianpatients
AT gopalakrishnanmahesh clinicalfeaturesmanagementandvisualoutcomeofpolypoidalchoroidalvasculopathyinindianpatients
AT rajputalpesh clinicalfeaturesmanagementandvisualoutcomeofpolypoidalchoroidalvasculopathyinindianpatients